Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674717018 | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3674718011 | Dimeticone (as simeticone) 125 mg and loperamide hydrochloride 2 mg chewable tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3674719015 | Dimethicone (as simethicone) 125 mg and loperamide hydrochloride 2 mg chewable tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
46596701000001118 | Simeticone 125mg / Loperamide 2mg chewable tablets | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Loperamide hydrochloride+simethicone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has active ingredient | Loperamide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has active ingredient | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has active ingredient | Simeticone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Product containing loperamide and simeticone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has active ingredient | Loperamide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Conventional release chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Product containing loperamide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength numerator value | 2 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has precise active ingredient | Simeticone | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has presentation strength numerator value | 125 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has precise active ingredient | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has basis of strength substance | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has basis of strength substance | Dimeticone | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Product containing loperamide and simeticone in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Product containing only loperamide and simeticone in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has precise active ingredient | Loperamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has basis of strength substance | Loperamide hydrochloride | true | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has basis of strength substance | Dimeticone | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has precise active ingredient | Simeticone | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has active ingredient | Simeticone | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Conventional release chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has active ingredient | Loperamide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Simeticone + Loperamide | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | tabletchewable.oral ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Oral route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Oral dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Conventional release chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Conventional release chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Conventional release chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has active ingredient | Loperamide hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has manufactured dose form | Conventional release chewable tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Dimeticone | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has specific active ingredient | Loperamide hydrochloride | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has specific active ingredient | Simeticone | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has dispensed dose form | Conventional release chewable tablet | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Has basis of strength substance | Dimeticone | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Loperamide hydrochloride+simethicone 2mg/125mg chewable tablet - product | Is a | False | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier | |
Imodium Plus chewable tablets (McNeil Ltd) | Is a | True | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier | |
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet | Is pack of | False | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier | |
Simeticone 125mg / Loperamide 2mg chewable tablets 12 tablet | Is pack of | False | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier | |
Simeticone 125mg / Loperamide 2mg chewable tablets 6 tablet | Is pack of | False | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier | |
Simeticone 125mg / Loperamide 2mg chewable tablets 6 tablet | Has VMP | True | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier | |
Simeticone 125mg / Loperamide 2mg chewable tablets 18 tablet | Has VMP | True | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier | |
Simeticone 125mg / Loperamide 2mg chewable tablets 12 tablet | Has VMP | True | Product containing precisely dimeticone (as simeticone) 125 milligram and loperamide hydrochloride 2 milligram/1 each conventional release chewable tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets